Skip to main content
. 2023 May 16;26(3):596–601. doi: 10.1038/s41391-023-00675-1

Table 1.

Patient Demographics and Disease Characteristic.

EPI Arm (n = 411) SOC Arm (n = 422) Statistics
Age, median (IQR) 65 (59–69) 65 (59–70) W = 83583.5, p = 0.37
PSA, median (IQR) 4.8 (4.0–6.0) 4.8 (3.6–6.1) W = 89058.5, p = 0.5
EPI Test Score, median (IQR) 29.6 (17.7–46.8) 28.2 (16.6–42.7) W = 90935.5, p = 0.22
PC Family History, n (%) χ2 = 0.20, p = 0.90
  Yes 61 (14.8) 59 (14.0)
  No 346 (84.2) 358 (84.8)
  Unknown 4 (1.0) 5 (1.2)
Ethnicity, n (%) χ2 = 4.24, p = 0.52
  Black 89 (21.7) 97 (23.0)
  Asian / Pacific Islander 13 (3.2) 10 (2.4)
  White 287 (69.8) 285 (67.5)
  Hispanic 7 (1.7) 8 (1.9)
  Other 8 (1.9) 17 (4.0)
  Unknown 7 (1.7) 5 (1.2)
DRE, n (%) χ2 = 4.73, p = 0.09
  Non-suspicious 365 (88.8) 357 (84.6)
  Suspicious 21 (5.1) 22 (5.2)
  Unavailable 25 (6.1) 43 (10.2)

DRE digital rectal exam, EPI ExoDx Prostate (IntelliScore), PC prostate cancer, PSA prostate specific antigen